Clinical Genetics Branch Eligibility Screening Survey
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Shanghai Henlius Biotech
University of Michigan Rogel Cancer Center
Pfizer
Shanghai Zhongshan Hospital
M.D. Anderson Cancer Center
Biocon Limited
Shanghai Zhongshan Hospital
University of Zurich
Bristol-Myers Squibb
Rapa Therapeutics LLC
Alvotech Swiss AG
Duke University
Bristol-Myers Squibb
Peking University Cancer Hospital & Institute
University of Pittsburgh
M.D. Anderson Cancer Center
University Hospital, Grenoble
Kaiser Permanente
OHSU Knight Cancer Institute
Qingdao Sino-Cell Biomedicine Co., Ltd.
Indiana University
Centre Georges Francois Leclerc
Nantes University Hospital
Second Life Therapeutics
Onchilles Pharma Inc
UNICANCER
McMaster University
Ohio State University Comprehensive Cancer Center
The Christie NHS Foundation Trust
AccSalus Biosciences, Inc.
OncoHost Ltd.
Petrov, Andrey
Eastern Cooperative Oncology Group
Hangzhou DAC Biotechnology Co., Ltd.
Vastra Gotaland Region
Xijing Hospital
Eastern Cooperative Oncology Group
Oncodesign Precision Medicine
Samsung Medical Center
Maria Sklodowska-Curie National Research Institute of Oncology
Xynomic Pharmaceuticals, Inc.
Rabin Medical Center
The University of Hong Kong-Shenzhen Hospital
Vastra Gotaland Region
Erasmus Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Royal Marsden NHS Foundation Trust
M.D. Anderson Cancer Center